期刊文献+

骨髓涂片和切片中的巨核细胞多形性改变在慢性骨髓增殖性疾病中的诊断意义 被引量:10

The diagnosis value of morphology changes of pleomorphic megakaryocytes in bone marrow smears and bone marrow sections in chronic myeloproliferative disorders
原文传递
导出
摘要 目的探讨骨髓涂片和切片中巨核细胞多形性改变在慢性MPD(CML-CP、ET、PV及PMF)中的诊断意义。方法182例MPD患者采用骨髓抽吸-活检双标本同步取材,获取骨髓涂片和切片标本。骨髓涂片行瑞氏-姬姆萨染色和CD41免疫组织化学染色,骨髓切片行苏木素-姬姆萨-酸性品红染色。将涂片和切片中的巨核细胞多形性形态定义为5类,分别为Ⅰ型(包含型);Ⅱ型(少分叶核型);Ⅲ型(巨大多分叶核型);Ⅳ型(小核固缩型)和Ⅴ型(脱落型)。骨髓涂片和切片中的巨核细胞簇分别计为未见巨核细胞簇状分布(0);小于6个的小簇巨核细胞组成为主(+1);至少6个以上的大簇巨核细胞组成为主(+2)3种情况。同步分析骨髓涂片和切片中的各型巨核细胞多形性变化以及巨核细胞簇的检出率。结果CML—CP组Ⅰ、Ⅱ、Ⅲ、Ⅳ、Ⅴ和正常型的巨核细胞在骨髓涂片中的检出率分别为(3.73±3.84)%、(14.19±7.62)%、(5.99±4.67)%、(34.37±10.79)%、(9.45±6.87)%及(32.28±7.67)%,在切片中的检出率分别为(3.13±2.30)%、(12.61±9.28)%、(4.94±4.27)%、(35.26±9.63)%、(9.47±5.89)%及(34.58±6.81)%,两者差异无统计学意义(t值分别为0.524、0.510、0.645、0.239、0.011、0.869,P均〉0.05)。ET组Ⅰ型巨核细胞的骨髓涂片检出率为(6.17±2.89)%,明显高于骨髓切片的(2.42±1.28)%,差异有统计学意义(t=7.183,P〈0.01);Ⅴ型巨核细胞的骨髓涂片检出率为(6.28±3.34)%,明显低于骨髓切片的(10.18±4.03),差异有统计学意义(t=3.940,P〈0.01);其余各型(Ⅱ、Ⅲ、Ⅳ和正常型)差异无统计学意义(t值分别为0.079、0.122、1.643、1.638,P均〉0.05)。PV组Ⅴ型巨核细胞的骨髓涂片检出率为(6.55±4.11)%,明显低于骨髓切片的(10.30±3.34)%,差异有统计学意义(t=2.351,P〈0.05),其余各型(Ⅰ、Ⅱ、Ⅲ、Ⅳ和正常型)差异无统计学意义(t值分别为1.635、0.301、0.132、0.704、0.681,P均〉0.05)。PMF组Ⅳ型巨核细胞的骨髓涂片检出率为(13.05±5.24)%,明显低于骨髓切片的(29.14±8.72)%,差异有统计学意义(t=5.245,P〈0.01);正常型巨核细胞在骨髓涂片检出率为(33.58±14.39)%,明显高于骨髓切片的(23.01±7.96)%,差异有统计学意义(t=2.132,P〈0.05),其余各型(Ⅰ、Ⅱ、Ⅲ和Ⅴ型)差异无统计学意义(t值分别为0.787、0.646、2.062、0.869,P均〉0.05)。CML.CP组和PV组中骨髓涂片和切片中巨核细胞簇检出率差异无统计学意义(χ^2=2.772,P〉0.05),均以小簇检出为主。ET组中骨髓涂片中小簇状分布的巨核细胞簇的检出率明显高于切片,而大簇状分布的巨核细胞簇检出率明显低于切片(r=13.748,P〈0.01)。PMF组中骨髓涂片无巨核细胞簇的检出率明显高于切片,而大簇状分布的巨核细胞簇的检出率明显低于切片(χ^2=18.741,P〈0.01)。结论骨髓涂片与骨髓切片同样可以观察到巨核细胞多形性改变,通过仔细观察巨核细胞多形性改变,我们认为对MPD的分型和鉴别诊断具有一定的参考价值。 Objective To explore the diagnosis value of morphology changes of pleomorphie megakaryoeytes in the bone marrow (BM) smears and BM sections in chronic MPD( CML-CP, ET,PV and PMF). Methods BM aspiration was taken in 182 patients of MPD aspiration and biopsy examination was performed synchronously to obtain the BM smears and BM sections samples. The BM smears were subjected to Wright/Giemsa stain and immunohistochemistry stain, while the BM sections were subjected to Haematoxylin-Giemsa-Fuchsin stain. The morphology of pleomorphic megakaryoeytes was classified into five groups, which were Ⅰ type ( inclusion type ), Ⅱ type ( hypolobulated muclei type ), Ⅲ type ( giant hyperlobulated nuclei type), Ⅳ type ( micro pyknotic type ), and Ⅴ type ( extrusion type ). The size of megakaryocytes clusters was recorded as no clusters(0), predominantly small clusters of fewer than 6 cells (1) or predominantly large clusters of at least 6 cells (2). The detection rates of various types of pleomorphie megakaryocytes and megakaryocytes clusters were both analyzed in the BM smears and BM sections. Resnits In CML-CP group, the detection rates were (3.73 ±3.84) %, ( 14. 19 ±7. 62 ) %, (5, 99 ±4.67)%,(34.37±10.79)%,(9.45±6.87)%, (32.28 ±7.67)% and 3.13 ±2.30)%,(12.61 ±9.28)%,(4.94±4.27)%,(35.26±9.63)%,(9.47±5.89)%,(34.58±6.81)% for Ⅰ type, Ⅱ type, Ⅲ type, Ⅳ type and Ⅴ type pleomorphic megakaryocyte in BM smears and BM sections. There were no significantly differences between the BM smears and BM sections( t value were 0. 524,0. 510,0. 645, 0. 239,0. 011,0. 869, all P 〉 0. 05 ). In ET group, the detection rate of I type [ (6. 17 ±2. 89 ) % ] in BM smears was significantly higher than that in BM sections [ 2. 42 ±1.28 ) % ] ( t = 7. 183, P 〈 0. 01 ), while the detection rate of V type [ (6. 28 ±3.34 ) % ] in BM smears was significantly lower than that in BM sections [ ( 10. 18 ±4. 03 ) % ] ( t = 3. 940, P 〈 0. 01 ). Besides these, the detection rates of other types were not significantly different between the BM smears and BM sections ( t value were 0. 079,0, 122,1. 643, 1. 638, all P 〉 0. 05 ). In PV group, the detection rate of Ⅴ type in BM smears [ ( 6.55 ±4, 11 ) % ] was significantly lower than that in BM sections [ ( 10. 30 ±3. 34 ) % ] ( t = 2. 351, P 〈 0. 05 ). However, the detection rates of the other types were not significantly different between the BM smears and BM sections (t value were 1. 635,0. 301,0. 132,0. 704,0. 681 ,all P 〉0. 05). In PMF group, the detection rate of Ⅳ type in BM smears [ (13. 05 ± 5. 24 )% ] was significantly lower than that in BM sections [ (29. 14 ±8.72)% ] (t =5.245, P 〈0.01). And the detection rate of normal type in BM smears [(33.58 ±14. 39 ) % ] was significantly higher than that in BM sections [ (23.01 ±7. 96 ) % ] ( t = 2. 132, P 〈 0. 05 ). Besides these, the detection rates of the other types were not significantly different between BM smears and BM sections( t value were 0. 787,0. 646,2. 062,0. 869, P 〉 0. 05 ). In CML-CP and PV groups, the detection rates of size of clusters were not significantly different between the BM smears and BM sections (χ^2 = 2. 772,P 〉 0. 05). In ET group, the detection rate of small clusters ( 1 ) in BM smears was obviously higher than that in BM sections, however, the detection rate of larger clusters (2) in BM smears was obviously lower than that in BM sections (χ^2 = 13. 748 ,P 〈 0. 01 ). In PMF group, the detection rate of no clusters(0) in BM smears was obviously higher than that in BM sections, however, the detection rate of large clusters(2) in BM smears was obviously lowers than that in BM sections (χ^2 = 18. 741 ,P 〈0. 01 ). Conclusions Both BM smears and BM sections can be applied to observe pleomorphic megakaryocytes. The morphology changes of pleomorphic megakaryocytes have certain reference values for identification of MPD subtypes and differential diagnosis.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2010年第2期143-148,共6页 Chinese Journal of Laboratory Medicine
基金 浙江省教育厅科研项目(Y200804673)
关键词 骨髓增殖性疾病 巨核细胞 骨髓检查 活组织检查 针吸 组织细胞学制备技术 Myeloproliferative disorders Megakaryocytes Bone marrow examination Biopsy,needle Histocytological preparation techniques
  • 相关文献

参考文献11

  • 1Jaffe ES, Harris NL, Stein H, et al. World health organization classification on tumours: pathology and genetics of tumours of heamatopoietic and lymphoid tissues. Lyon: IARC Press, 2001 : 17-44.
  • 2Michiels JJ, De Raeve H, Bememan Z, et al. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders (MPD). Semin Thromb Hemostas,2006,32:307-340.
  • 3Wilkins BS, Erber WN, Bareford D, et al. Bone marrow pathology in essential thrombocytemia : interobserver reliability and utility for identifying disease subtypes. Blood ,2005,111:60-70.
  • 4Nakazawa M, Ninomiya H, Aoki Y, et al. Identification of neoplastically proliferating megakaryoblasts. Nippon Ketsueki Gakkai Zasshi, 1986, 49 : 115-126.
  • 5Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008:31-50.
  • 6Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms : The 2008 World Health Organization criteria and point-of -care diagnostic algorithms. Leukemia, 2008, 22 : 14-22.
  • 7Kilpivaara O, Levine RL. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia, 2008, 22: 1813-1817.
  • 8Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations form an ad hoc international export panel. Blood, 2007, 110 : 1092-1097.
  • 9Michiels JJ, Raeve HD, Hebeda K, et al. WHO bone marrow feature and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders. Leukemia Research, 2007, 31 : 1031-1038.
  • 10Schmitt A, Drouin A, Masse JM, et al. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis. Leuk lymphoma, 2002, 43:719-724.

同被引文献62

  • 1马松涛,柳华平,杨昌芳.骨髓涂片联合血小板参数在血液病临床检测诊断中的作用[J].中医学报,2019,0(S2):0101-0102. 被引量:1
  • 2陈诚,王佳,李义德,郑晓敏,张晓春.免疫性血小板减少症患儿外周血CD4+CD25+调节T细胞和Th17细胞的变化[J].宁夏医科大学学报,2013,35(8):864-867. 被引量:8
  • 3陈辉树,张大龙,梁晓岚,胡小莉,甘芾,吴彩志.真性红细胞增多症骨髓病理学观察[J].中华血液学杂志,1994,15(6):319-319. 被引量:5
  • 4熊川,李兰馨,程乃俊.骨髓涂片联合骨髓活检在多系造血细胞减少患者中的诊断价值[J].川北医学院学报,2006,21(2):127-129. 被引量:4
  • 5Michiels JJ,De Raeve H,Hebeda K,et al.WHO bone marrow features and European clinical,molecular,and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders[J].Leuk Res,2007,31(8):1031-1038.
  • 6Balduini A,Badalucco S,Pugliano MT,et al.In vitro megakaryocyte differentiation and proplatelet formation in ph-negative classical myeloproliferative neoplasms:distinct patterns in the different clinical phenotypes[J].PloS One,2011,6(6):e21015.
  • 7Vardiman JW.The world health organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues:an overview with emphasis on the myeloid neoplasms[J].ChemBiol Interact,2010,184(1-2):16-20.
  • 8Passamonti F,Malabarba L,Orlandi E,et al.Polycythemiavera in young patients:a study on the longterm risk of thrombosis,myelofibrosis and leukemia[J].Haematologica,2003,88(1):13-18.
  • 9Thiele J,Kvasnicka HM,Orazi A.Bone marrow histopathology in myeloproliferative disorders-current diagnostic approach[J].Seminars in hematology,2005,42(4):184-195.
  • 10Kralovics R,Passamonti F,Buser AS,et al.A gain-offunctionmutation of JAK2 in myeloproliferativedisorders[J].N Engl J Med,2005,352(17):1779-1790.

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部